In patients with HbA1c < 7%, 88, 5% received prescribed oral monotherapy; with HbA1c 7 - <8.5%: 62% and 32% received oral drug combination and monotherapy, respectively; with HbA1c 8.5 - <10%: 65.5% received oral drug combination and 31% used insulin; with HbA1c ≥ 10%: 66.5% and 32.5% used insulin and oral drug combinations, respectively.